Trials Starting With "T"

TACTICS-TIMI 18: Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy

      -Trial Overview by Dr. Christopher Cannon (AHA 2000)

      -A Risk Score for Predicting Coronary Artery Bypass Surgery in Patients with Non-ST Elevation Acute Coronary Syndromes by Dr. Sai Sadanandan

      -Economics and QOL Substudy

Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring Decrease Early Stent Thrombosis

      -Trial Overview by Dr. Laurent Bonello

TAPAS: Thrombus Aspiration during Percutaenous Coronary Intervention in Acute Myocardial Infarction

      -Mortality and Reinfarction at 1 Year by Dr. F. Zijlstra

TARGET: Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial

      -Preliminary Results (AHA 2000)

      -6-Month Results (2001)


TAVR-PARTNER: From Concept to Mortality Benefit

      -State of TAVR by Dr. Jeffrey Moses (C3 Complex Intervention Meeting 2011)


TAXUS: The TAXUS™ Paclitaxel-Eluting Stent Program

      -Trial Overview

TAXUS II: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent

      -Two Year Follow-Up (TCT 2004)

      -Two Year Follow-Up (TCT 2002)

      -TAXUS II: Slow Release Formula: An International, Randomized, Multicenter, Blinded Trial of TAXUSTM NIRx MR Stent (TCT 2002)

TAXUS IV: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent

      - 2-Year Clinical Results

      -Two Year Follow-Up (TCT 2004)

      -Slow-rate release polymer-based paclitaxel-eluting stent compared with bare stent in patients with single de novo coronary lesionsp (TCT 2003)

TAXUS V: Outcomes of the Polymer-Based, Paclitaxel-Eluting TAXUS Stent in Complex Lesions

      -Principal Clinical and Angiographic Results from the TAXUS-V Pivotal Randomized Trial by Dr. Gregg W. Stone (ACC 2005)

      -Slow-rate release polymer-based paclitaxel-eluting stent compared with bare stent in patients with single complex coronary lesions by Dr. Gregg W. Stone (ACC 2005)

      -Myonecrosis and sidebranch patency concerns are short-term issues with no long-term consequences, and the benefits are undeniable by Dr. Jeffrey J. Popma

TAXUS V IRS: Paclitaxel-eluting Stents vs Brachytherapy for In-stent Restenosis

      -Trial Overview by Dr. Gregg W. Stone (ACC 2006)

TAXUS ATLAS: A Multi-Center, Single-Arm Study of the TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions

      -First Report of Nine- and Twelve-Month Clinical and Angiographic Results by Dr. Mark A. Turco and Dr. John A. Ormiston (TCT 2006)

      -TAXUS ATLAS 9-Month Results: Evaluation of TAXUS Liberté vs. TAXUS Express Trial by Dr. Mark A. Turco (EuroPCR 2006)

      -Small Vessel and Long Lesion: First Report of Nine-Month Clinical and Angiographic Results by Dr. Mark A. Turco and Dr. John A. Ormiston (TCT 2007)


Temporal Trends in Clinical Trials of NSTE ACS Over 15 Years:

      -Trial Overview by Dr. Mark Chan


TETAMI: Treatment with Enoxaparin and Tirofiban in acute MI

      -Trial Overview by Dr. M. Cohen

TIGER-PA: Tirofiban Given in the Emergency Room Before Primary Angioplasty

      -Trial Overview by Dr. David P. Lee

TIME: Effect of Timing of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells on Left Ventricular Function Following STEMI

      -Trial Overview by Dr. Jay H. Traverse (AHA 2012)

TIMI Trials: Thrombolysis in Myocardial Infarction Trials

      -Overview of TIMI 1 through TIMI 35

TIMI 11A and 11B

      -Trial Overviews by Dr. Elliott Antman

TIMI-31: Thrombolysis in Myocardial Infarction 31

      -A Phase II, Open-Label, Multi-Center, Dose Escalation Study to Determine the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BB-10153 in ST Segment Elevation Myocardial Infarction

Completed TIMI Trials

      -Primary Results

Tirofiban Meta-Analysis

      -30-Day Results by Dr. Marco Valgimigli

TITAN-TIMI 34: Time to Integrilin Therapy in Acute myocardial infarctioN

      -Time to Integrilin Therapy in Acute myocardial infarctioN (TITAN)-TIMI 34

      -Trial results

TNT: Treating to New Targets Study

      -Trial Overview by Dr. John C. LaRosa (ACC 2005)

TOPSTAR: Effect of Additional Temporary Glycoprotein IIb-IIIa Receptor Inhibition on Troponin Release in Elective Percutaneous Coronary Interventions After Pretreatment With Aspirin and Clopidogrel

      -Trial Overview by Dr. AW BONZ


TORPEDO: Percutaneous Endovenous Intervention Compared to Anticoagulation Alone in Patients with Deep Venous Thrombosis

      -A Prospective Randomized Trial of Percutaneous Endovenous Intervention Compared to Anticoagulation Alone in Patients with Deep Venous Thrombosis by Dr. Mohsen Sharifi (TCT 2010)


TOSCA-2: Total Occlusion Study of Canada

      -Trial Overview by Dr. Vladimir Dzavik (AHA 2006)


TRA-CER: The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome

      -Trial Overview by Dr. Kenneth W. Mahaffey (AHA 2011)


      -Update on the New Antiplatelet Agents: PAR-1 Inhibitors by Dr. David J. Moliterno

      -Results of a Multinational Randomized, Double-Blind, Placebo-Controlled Study of a Novel Thrombin Receptor Antagonist SCH 530348 in PCI by Dr. David J. Moliterno

TRANSFER-AMI: Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction

      -Trial Overview by Dr. Warren J. Cantor


TRA 2°P: TIMI 50 Trial: Evaluation of a Novel Antiplatelet Agent for Secondary Prevention in Patients with Atherosclerotic Disease

      -Results of the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events by Dr. David A. Morrow (ACC 2012)



      -Is there a Critical Value of Daily Atrial Tachyarrhythmia Burden from Device Diagnostics that Raises Stroke Risk? by Dr. Taya V. Glotzer


TRI: An Emerging, Mini-invasive PCI New Model from Treating LM Bifurcation Lesion: Strategy and Tactics in Treating Bifurcated LM Lesion

      -Overview by Dr. Yuejing Yang (C3 Complex Intervention Meeting 2011)

TRIANA: Tratamiento del Infarto Agudo de miocardio en Ancianos

      -Primary Angioplasty versus Fibrinolysis in the Very Elderly by Dr. Hector Bueno (ESC 2009)


TRIGGER-PCI: Testing Platelet Reactivity in Patients Undergoing Elective Stent Replacement on Clopidogrel to Guide Alternative Therapy with Prasugrel

      -Primary Results by Dr. Dietmar Trenk (TCT 2011)

TRILOGY ACS: Prasugrel vs. Clopidogrel in Patients with Non-ST-Segment Elevation ACS Who Are Medically Managed After Coronary Angiography

      -Prasugrel versus clopidogrel for patients with unstable angina/NSTEMI who are medically managed without revascularization by Dr. Matthew Roe and Dr. Magnus Ohman (ESC 2012)

      -Trial Results by Dr. Stephen D. Wiviott et al. (TCT 2012, AHA 2012)

TRILOGY ACS Platelet Function Sub-study: First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial

      -Trial Overview by Dr. Paul Gurbel and Dr. Magnus Ohman (AHA 2012)

TRIUMPH: Tilarginine Acetate Injection In A Randomized International Study In Unstable Mi Patients With Cardiogenic Shock

      -Trial Overview by Dr. Yuri B. Pride (AHA 2008)

Troponin I

      -In Early Diagnosis of Acute Myocardial Infarction by Dr. Stefan Blankenberg


TWENTE: A Prospective, Randomized Trial of Zotarolimus-Eluting Stents and Everolimus-Eluting Stents in Patients with Coronary Artery Disease

      -Trial Overview by Dr. Clemens von Birgelen (TCT 2011)

TYPHOON: Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty

      -Trial Overview by Dr. Christian Spaulding (ACC 2006)

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at For further information please see the Policy section. Webmaster